|
CCT8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.981800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.818600E-03 |
| Normal-vs-Stage2 |
4.694800E-01 |
| Normal-vs-Stage3 |
6.729800E-01 |
| Normal-vs-Stage4 |
8.428000E-01 |
| Stage1-vs-Stage2 |
2.484000E-01 |
| Stage1-vs-Stage3 |
3.874100E-02 |
| Stage1-vs-Stage4 |
3.129600E-02 |
| Stage2-vs-Stage3 |
7.197400E-01 |
| Stage2-vs-Stage4 |
5.851200E-01 |
| Stage3-vs-Stage4 |
8.467200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.308200E-02 |
| Normal-vs-AfricanAmerican |
6.458800E-01 |
| Normal-vs-Asian |
5.597800E-01 |
| Caucasian-vs-AfricanAmerican |
4.888200E-01 |
| Caucasian-vs-Asian |
9.264000E-01 |
| AfricanAmerican-vs-Asian |
8.660600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.658300E-02 |
| Normal-vs-Female |
1.107220E-01 |
| Male-vs-Female |
9.164600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.255000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.182300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.517380E-01 |
| Normal-vs-Age(81-100Yrs) |
8.934800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.141000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.578000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.078400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.533200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.293800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.923400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.407800E-02 |
| Normal-vs-Grade 2 |
1.377340E-03 |
| Normal-vs-Grade 3 |
3.070200E-01 |
| Normal-vs-Grade 4 |
3.461800E-01 |
| Grade 1-vs-Grade 2 |
6.648800E-01 |
| Grade 1-vs-Grade 3 |
2.565000E-01 |
| Grade 1-vs-Grade 4 |
4.634300E-02 |
| Grade 2-vs-Grade 3 |
2.742500E-02 |
| Grade 2-vs-Grade 4 |
4.775300E-04 |
| Grade 3-vs-Grade 4 |
8.862000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.82045999999048E-05 |
| Normal-vs-ccB subtype |
8.636800E-01 |
| ccA subtype-vs-ccB subtype |
2.2236999999925E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.751770E-01 |
| Normal-vs-N1 |
7.953600E-01 |
| N0-vs-N1 |
4.749200E-01 |
|
|
